5NN Stock Overview
Provides information technology services to life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NNIT A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 11.96 |
| 52 Week High | DKK 17.80 |
| 52 Week Low | DKK 10.94 |
| Beta | 1.08 |
| 11 Month Change | -16.13% |
| 3 Month Change | -11.93% |
| 1 Year Change | 3.82% |
| 33 Year Change | -16.25% |
| 5 Year Change | -8.84% |
| Change since IPO | -43.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5NN | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -0.3% | 4.2% | 1.1% |
| 1Y | 3.8% | -30.1% | 7.2% |
Return vs Industry: 5NN exceeded the German Healthcare Services industry which returned -31.4% over the past year.
Return vs Market: 5NN underperformed the German Market which returned 8.6% over the past year.
Price Volatility
| 5NN volatility | |
|---|---|
| 5NN Average Weekly Movement | 6.4% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5NN has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 5NN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,700 | Par Fors | www.nnit.com |
NNIT A/S provides information technology services to life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia. The company provides data and AI solutions; cybersecurity solutions, including zero trust and cloud security, cybersecurity consulting, and compliance and privacy solutions; and SAP solutions. It also offers NNIT Veeva powerhouse; D365 and power; drug safety; clinical; regulatory affairs; manufacturing and supply chain; quality; migration powerhouse; compliance; and laboratory solutions, as well as offers custom application development and ESG advisory solutions.
NNIT A/S Fundamentals Summary
| 5NN fundamental statistics | |
|---|---|
| Market cap | €305.43m |
| Earnings (TTM) | €9.79m |
| Revenue (TTM) | €245.10m |
31.2x
P/E Ratio1.2x
P/S RatioIs 5NN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5NN income statement (TTM) | |
|---|---|
| Revenue | DKK 1.83b |
| Cost of Revenue | DKK 1.37b |
| Gross Profit | DKK 456.00m |
| Other Expenses | DKK 383.00m |
| Earnings | DKK 73.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.94 |
| Gross Margin | 24.95% |
| Net Profit Margin | 3.99% |
| Debt/Equity Ratio | 53.8% |
How did 5NN perform over the long term?
See historical performance and comparison